MiR-26a is downregulated in A549 cells and BLM-induced mouse models, and its overexpression diminishes epithelial-mesenchymal transition (EMT) through targeting high mobility group AT-hook 2 (HMGA2), a main positive regulatory factor in EMT (Liang et al., 2014a). The gene discussed is HMGA2; the disease is Bloom syndrome.